TANAKA CAPITAL MANAGEMENT INC

Q3 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    45

  • Value ($000)

    $56

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0000816788
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
H
HTD

Corcept Therapeutics

COM
218352102
$9.24K
17 %

111,209

U
UAMY

United States Antimony

COM
911549103
$5.13K
9 %

827,035

N
NVDA

Nvidia

COM
67066G104
$4.64K
8 %

24,879

N
NXE

NexGen Energy

COM
65340P106
$3.96K
7 %

442,625

A
AAPL

Apple Computing

COM
037833100
$3.30K
6 %

12,972

N
NUVB

Nuvation Bio Inc.

COM
67080N101
$2.54K
5 %

685,105

I
IJR

Intellia Therapeutics

COM
464287804
$2.49K
5 %

144,225

S
SYM

Symbotic

COM
87151X101
$2.34K
4 %

43,454

A
AFL

AFLAC Inc.

COM
001055102
$2.27K
4 %

20,369

C
CPRX

Catalyst Pharmaceuticals

COM
14888U101
$2.25K
4 %

114,418

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 45